Covalently coupling nucleic acids to a gold nanoparticle (AuNP) surface has been demonstrated for generating effective gene therapy agents to modify cellular protein expression. The therapeutic efficacy of the approach is anticipated to be impacted by the length of time the nucleic acid sequence resides in the endolysosomal pathway once transfected into a cell. It is believed that the dynamics of the processing should reflect the linkage chemistry of the DNA to the AuNP surface. In this manuscript the dynamics of nanotherapeutic uptake, nucleic acid release, and gene processing are investigated in vitro for a AuNP-nucleic acid delivery platform transfected into A375 human melanoma cells, as a function of the nucleic acid-gold linkage chemistry. The dynamics of cell processing of the single monodentate thiol (SX), bidentate dual thiol (SS), or mixed bidentate thiol plus amine (SN) coordination of nucleic acids to the AuNP surface are evaluated using a multicolor nanosurface energy transfer bio-optical transponder (SET-BOT) technology. The use of live-cell fluorescence microscopy allows for the direct visualization of the uptake and localization of a lipofectamine-packaged SET-BOT using a dye (DL700) that is not quenched in the proximity of the AuNP, while fluorescence "turn on" of a dye that is proximally quenched by the AuNP (DL488) is used to report on the dynamics of release of the nucleic acid cargo within the cell. For protein expression following transcription of the gene, the emission signature of a red fluorescent protein, tdTomato, is monitored. The intracellular rates of DNA release from the AuNP surface once endosomally packaged within the A375 human melanoma cells were found to follow the binding activity series: bidentate thiol > bidentate thiol plus amine > monodentate thiol, consistent with the strength of multidentate chelation, paired with the stabilizing influence of π-backbonding of thiols compared to σ-donation in amines, when bound to a gold surface.